铁:肝细胞癌治疗的新有前途的标
Qiaoping Xu1, Lanqi Ren2, Ning Ren2
1Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Westlake University School of Medical, Hangzhou, 310006, China.
Molecular and cellular biochemistry
|December 5, 2023
概括
肝细胞癌 (HCC) 存在诊断和治疗方面的挑战. 作为细胞死亡途径的铁灭,通过向铁代谢和脂质过氧化,显示出新的HCC疗法的前景.
科学领域:
- 在瘤学瘤学.
- 细胞死亡机制 细胞死亡机制
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的全球性癌症,由于晚期诊断和药物耐药性,患者的生存率很差.
- 铁,一种新型的依赖铁的细胞死亡形式,已经成为癌症治疗的有希望的途径.
- 了解铁灭的机制对于开发有效的HCC治疗至关重要.
研究的目的:
- 在肝细胞癌的背景下审查当前对铁亡的理解.
- 探索涉及HCC.ferroptosis的信号通路和治疗策略.
- 确定未来的研究方向,以应对基于铁灭的HCC治疗的挑战.
主要方法:
- 文献综述侧重于铁,铁代谢,脂质过氧化和HCC中的抗氧化防御.
- 对涉及铁和HCC的信号通路的分析.
- 对HCC.目前和新兴的铁灭向治疗方法的评估.
主要成果:
- 铁化研究使人们对癌症中的铁代谢和脂质过氧化有了更深入的了解.
- 铁和HCC之间存在强烈的相关性,突出其治疗潜力.
- 基于铁灭的策略正在化学疗法,免疫疗法,放射疗法和纳米疗法中被探索.
结论:
- 铁化为克服HCC耐药性和改善患者治疗结果提供了一个重要的治疗窗口.
- 向铁亡途径为新型HCC治疗提供了一个有希望的策略.
- 对铁亡机制和治疗应用的进一步研究可能会彻底改变HCC管理.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.5K
相关概念视频
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K